Matthew Sparks

NephSIM Nephrons - Applications for the 2026 NephSIM Nephrons & National Kidney Foundation Mentorship Program are now open for medical students & residents wanting to learn more about nephrology careers. Apply here by…

Calling all medical students & residents 📢 The 2026 NephSIM Nephrons program offers faculty mentorship, small group learning, & career panels in nephrology.

Deadline: Nov 13th
More Info:

Kidney Translation Podcasts 🎙️ from @asnkidney.bsky.social @asnpublications.bsky.social @nephrosparks.bsky.social
#Nephpearls #NephSky

👉🏼 journals.lww.com/asnjournals/...

New from #NephFaculty Dr Phekoo and PD Dr Sparks in @ASNPublications #Kidney360

Use of the Desmopressin Clamp in Hyponatremia: Smooth Sailing or Turbulent Waters?

journals.lww.com/kid...

NephJC 2025 Fall Pledge Drive — NephJC Help keep NephJC a vital, original, and unbiased source of medical education.

I donated to #NephJC

www.nephjc.com/news/2025/9/...

Take a listen to all of the @asnpublications.bsky.social ASN Kidney Translation Kidney Podcast series here

journals.lww.com/asnjournals/...

Had a great time at @nbluniv.bsky.social

Congrats to 10 years

NephMadness Canada trophy, ;)

Saturday is a dialysis day!, 🙏💛

ICYMI: the #NephJC @ajkd.bsky.social #NephMadness Canada kidney cup, cc: Dr. @nephrosparks.bsky.social resides in Atlantic Canada this year,🏆👊🤓😎#ThingsThatMakeYouSmile 🤓😃🙏💛

Could interleukin-6 have the potential to lead to treatments for calciphylaxis? The rare and life-threatening complication takes center stage in a new study described by Aarushi Varshney and Matthew Sparks. kidney.pub/KN1707-20 #ASNKidneyNews

@nephrosparks.bsky.social

A Day in the Life of a Duke Nephrology Fellow

⬇️
youtu.be/xnAjinYC1tA...

Baclofen Toxicity in Kidney Disease - PubMed Baclofen, a commonly prescribed muscle relaxant, is primarily excreted via the kidneys; toxicity is a potentially serious adverse outcome in patients with decreased kidney function. We describe a pati...

Also: baclofen in renal failure? 😱

pubmed.ncbi.nlm.nih.gov/28899601/

@nephrosparks.bsky.social

Exciting, clear, and concise summary by @nephrosparks.bsky.social and Dr. Arash Ataei of RGLS4326, a potential breakthrough in ADPKD research.
www.kidneynews.org/view/journal...

Could gene-targeted therapy be coming for autosomal dominant polycystic kidney disease? Farabursen, a new medication acquired by Novartis offers to potentially impact cyst formation and even regression. kidney.pub/KN1707-07 #ASNKidneyNews

@nephrosparks.bsky.social

Big Beautiful Bill is Downright Ugly for Kidney Patients Tune in for the latest research and perspectives on kidney health from NKF.

The so-called ‘Big Beautiful Bill’ that passed the Senate today is a giant leap backward for people living with kidney disease. NKF urges Congress to reject these harmful provisions. www.kidney.org/press-room/b...

The first installment of the ASN Transforming Vascular Access Together (TDAT) Videos is out

First installment is on how to identify vascular access types

Watch it here ✅

youtu.be/u6MXVL2lD7s

Interested in developing educational materials about the link between kidney dysfunction and cardiovascular disease? @nephrosparks.bsky.social details how to get involved and introduces a new contest from the American Heart Association. kidney.pub/KN1706-09

#ASNKidneyNews

Great selection. Congrats

ASN welcomes Professor Charuhas V. Thakar, MD, FASN, as the new Editor-in-Chief of Kidney360. In this role, Dr. Thakar aspires to "disseminate cutting-edge research in diverse areas of nephrology." His term begins January 1, 2026. kidney.pub/4e466Kr

#ASNKidney360

#NephMadness 2026: Call for Topic Suggestions We’ve barely caught our collective breath from NephMadness 2025, but it’s already time to start thinking about NephMadness 2026! Which topics would you like to see in next year’s …

Did we just wrap up #NephMadness 2025? Yes...

Is it time to start planning #NephMadness 2026? YES!

Share your ideas for next year's tournament!

bit.ly/NM26Ideas

@nephrosparks.bsky.social @annaburgner.bsky.social‬ @kidneywars.bsky.social @jrkott27.bsky.social @catochita.bsky.social

The Role of the Kidney in Cardiovascular Disease Educational Tools Contest Reduced kidney function is an independent risk factor and confers a high risk of cardiovascular.

Don’t forget to send in teaching tool entries to “The Role of the Kidney in Cardiovascular Disease Educational Tools Contest”
#kcvd @ahajournals.bsky.social @ahascience.bsky.social
professional.heart.org/en/professio...

Congrats to our 2025 Fellowship Graduates. Dr Phekoo, Dr Catanese, Dr Turk, Dr Sreenivasan, and Dr Vaidya

We are proud of your accomplishments & grateful for the impact each of you have made on our division, our fellowship program, and your patients

#NephForward #FellowGrad

#NephMadness 2026: Call for Topic Suggestions We’ve barely caught our collective breath from NephMadness 2025, but it’s already time to start thinking about NephMadness 2026! Which topics would you like to see in next year’s …

Did we just wrap up #NephMadness 2025? Yes...

Is it time to start planning #NephMadness 2026? YES!

Share your ideas for next year's tournament!

bit.ly/NM26Ideas

@nephrosparks.bsky.social @annaburgner.bsky.social‬ @kidneywars.bsky.social @jrkott27.bsky.social @catochita.bsky.social

#NephMadness 2026: Call for Topic Suggestions We’ve barely caught our collective breath from NephMadness 2025, but it’s already time to start thinking about NephMadness 2026! Which topics would you like to see in next year’s …

Did we just wrap up #NephMadness 2025? Yes...

Is it time to start planning #NephMadness 2026? YES!

Share your ideas for next year's tournament!

bit.ly/NM26Ideas

@nephrosparks.bsky.social @annaburgner.bsky.social‬ @kidneywars.bsky.social @jrkott27.bsky.social @catochita.bsky.social

#NephMadness 2026: Call for Topic Suggestions We’ve barely caught our collective breath from NephMadness 2025, but it’s already time to start thinking about NephMadness 2026! Which topics would you like to see in next year’s …

Did we just wrap up #NephMadness 2025? Yes...

Is it time to start planning #NephMadness 2026? YES!

Share your ideas for next year's tournament!

bit.ly/NM26Ideas

@nephrosparks.bsky.social @annaburgner.bsky.social‬ @kidneywars.bsky.social @jrkott27.bsky.social @catochita.bsky.social

We are excited to announce that Dr. Opeyemi Olabisi will be appointed as the next Chief of Nephrology in the Department of Medicine

medicine.duke.edu/ne...

The biggest no duh trial ever. Shows they have money to just blow.

Check out ALL 8 of the ASN Kidney Translation Podcast episodes here

journals.lww.com/asnjournals/...

CAR-T Cell Therapy wins #NephMadness 2025! @nephrosparks.bsky.social recaps this year's tournament and the thrilling matchup.
bit.ly/KN1705-20
#ASNKidneyNews

New ASN Kidney Translation Podcast: Dr. @nephrosparks.bsky.social discusses key ADPKD studies: circadian clock disruption and cyst growth (JASN), depressive symptoms in adults with ADPKD (Kidney360), and biomarker-based kidney outcome prediction (CJASN). https://bit.ly/KTPOD575

Just use Spiro or Eplerenone. Much cheaper option.

Might need to score those.